Iridium Organometallic Complex for High Color Purity Green Emission

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current phosphorescent materials for light-emitting elements have limitations in color purity and efficiency, with existing organometallic complexes often resulting in low hole-injection properties and high driving voltages due to their electronic structure.

Innovation Solution

Development of a novel organometallic complex incorporating an iridium central metal with a pyrido[2,3-b]indole and pyrimidine skeleton ligand, which enhances hole-injection properties and narrows the band gap, allowing for efficient green light emission with high color purity.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If conventional organometallic complexes are used, then phosphorescence emission is achieved, but hole-injection properties deteriorate and driving voltage increases

Engineering Contradiction:
Improvehole-injection propertiesVSAvoiddriving voltage
Core Design Contradiction:
ReliabilityVSStress or pressure

Solution Approach 1:

The patent modifies the ligand structure by introducing electron-donating groups (such as methoxy groups) at specific positions of the pyrido[2,3-b]indole skeleton, which changes the electronic parameters of the complex. This increases the HOMO level and improves hole-injection properties, thereby reducing driving voltage while maintaining phosphorescence emission

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent creates a composite ligand system combining pyrido[2,3-b]indole skeleton with pyrimidine or triazine rings, forming a complex with optimized electronic structure. This composite structure achieves both good hole-injection properties and efficient phosphorescence emission, resolving the contradiction between reliability and operating conditions

Inventive Principle:
Principle #40Composite materials

2Productivity

If phosphorescent materials are used to improve internal quantum efficiency, then triplet excitation energy conversion is enhanced, but color purity deteriorates

Engineering Contradiction:
Improveinternal quantum efficiencyVSAvoidcolor purity
Core Design Contradiction:
ProductivityVSManufacturing precision

Solution Approach 1:

The patent introduces specific substituents (electron-donating groups) at localized positions (positions 5 or 6 of the pyrido[2,3-b]indole skeleton) to optimize the emission characteristics. This local modification narrows the emission spectrum while maintaining high internal quantum efficiency, achieving both productivity and manufacturing precision

Inventive Principle:
Principle #3Local quality

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The novel organometallic complex improves light-emitting efficiency by facilitating easy carrier injection and transport, reducing driving voltage, and achieving high color purity through its specific electronic structure.

Implementation Method 1

a compound capable of converting triplet excitation energy into light emission is called a phosphorescent compound (phosphorescent material)

Methodology Applied
Scientific EffectPhosphorescence: Phosphorescence

Implementation Method 2

a compound capable of converting singlet excitation energy into light emission is called a fluorescent compound (fluorescent material)

Methodology Applied
Scientific EffectFluorescence: Fluorescence

Data Source

PatentUS9843002B2Organometallic complex, light-emitting element, light-emitting device, electronic device, and lighting device
Publication Date: 2017.12.12 SEMICON ENERGY LAB CO LTD
  • US9843002B2 patent drawing
  • US9843002B2 patent drawing
  • US9843002B2 patent drawing

AI summary

A novel organometallic complex having high color purity is provided. The organometallic complex includes a structure which includes iridium and a ligand and is represented by a general formula (G1). The ligand includes a pyrido[2,3-b]indole skeleton and a pyrimidine skeleton bonded to the 3-position of the pyrido[2,3-b]indole skeleton. The 2-position of the pyrido[2,3-b]indole skeleton and the pyrimidine skeleton are each bonded to the iridium. In the general formula (G1), R1 to R9 each independently represent any of hydrogen, a substituted or unsubstituted alkyl group having 1 to 6 carbon atoms, a substituted or unsubstituted aryl group having 6 to 13 carbon atoms, and a substituted or unsubstituted heteroaryl group having 3 to 12 carbon atoms.